Adults aged ≥50 years boosted with SARS-CoV-2 mRNA vaccines less likely to experience adverse reactions after second booster than during initial booster - News-Medical.Net

A new study monitored the safety of the second booster dose of SARS-CoV-2 messenger ribonucleic acid vaccination among those ≥50 Years.

A recent article published in the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report (MMWR) monitored the safety of the second booster dose of severe acute respira… [+5189 chars]

full article...